Indar Ownership Uncertainties Prevail

Uncertainty surrounding the ownership of insulin specialist Indar rumbles on, following a decision by the Supreme Court of Ukraine to re-assign the case to the Court of the First Instance. It is reported that this decision sees the State Treasury move closer to regaining the majority stake in the company from little-known UK investment firm Gerist Invest. While BMI bears no judgement over which party should rightfully control the company, it is our view that a swift resolution should be sought in order to free up resources to develop Indar's

To read the full article, please choose one of the following options: